In our published article, we have elucidated that ISG15 acts as an independent prognostic marker for lung adenocarcinoma (LUAD) and undergoes ISGylation with ESRP1, reducing ESRP1 degradation. This evidence concerns the gene ISG15 and lung adenocarcinoma.